date,title,source
Oct-17-18,"Analysis: Positioning to Benefit within New York, KB Home, Sangamo Therapeutics, INTL FCStone, Maiden, and MobileIron  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Oct-18-18,Is Sangamo Therapeutics Inc. a Buy?,Motley Fool
Oct-29-18,What's in Store for Sangamo (SGMO) This Earnings Season?,Zacks
Nov-01-18,Sangamo Therapeutics Announces Third Quarter 2018 Conference Call and Webcast,PR Newswire
Nov-06-18,Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences,PR Newswire
Nov-08-18,"Sangamo Therapeutics (SGMO) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-08-18,Sangamo Therapeutics Reports Third Quarter 2018 Financial Results,PR Newswire
Nov-14-18,Here's Why Sangamo Therapeutics Lost 12% Today,Motley Fool
Nov-14-18,Cutting-edge biotech Sangamo stock dives 13% after JPMorgan cites growing skepticism in downgrade,MarketWatch
Nov-14-18,Sangamo stock drops after J.P. Morgan downgrade,MarketWatch
Nov-15-18,"Sangamo's Shares Drop on Rating Downgrade, Pipeline Woes",Zacks
Nov-15-18,Cutting-edge biotech Sangamo stock dives 12% after JPMorgan cites growing skepticism in downgrade,MarketWatch
Nov-20-18,Gilead's Vemlidy Gets Approval in China for HBV Infection,Zacks
